• Develop immunogenicity assessment strategy for biotherapeutic candidates consistent with the immunogenicity risk assessment and with applicable guidance and best practices. • Collaborate with bioanalytical scientists in the development of ADA and NAb assay methods. • Support pre-clinical, safety and clinical teams conducting in vivo studies to ensure appropriate testing of immunogenicity. • Interpret and present immunogenicity data and provide assessment of potential clinical impact to project teams and management. • Author components of study reports, regulatory submissions, and technical documents. • Work collaboratively and communicate effectively with multidisciplinary teams to design and prosecute studies in line with the strategic direction of the project. • Self-starter, able to prioritize work, adapt to shifting priorities, and work efficiently with minimal supervision.